ViBo Health is a startup that will offer some of the benefits of traditional laboratory tests without needing to give blood and wait for the meta-analysis. The company is working on instrumentation that will scan a person’s wrist using hardware based on magnetic resonance spectroscopy (MRS), combined with advanced signal processing and machine learning.
The 10-second scan, using non-invasive molecular spectroscopy, will provide real-time analysis of various metabolic measurements. When used regularly, this data will show an individual’s health trends by outlining changing vitamin levels, cholesterols and diabetes parameters.
ViBo Health intends to place scanners in high-traffic venues such as gyms and pharmacies. As well as giving users an insight into their own health and fitness status, the anonymised data would be of use to clinicians and health workers to analyse more general health trends.
Dr Gil Travish co-founded ViBo Health in 2020. He became an SME Leader in 2017, when he was Chief Science Officer at Adaptix, another company that he co-founded. Gil says that the SME Leaders programme “has been instrumental in my development as a founder and leader of startups. With ViBo Health, it has helped me with networking and defining the company through multiple roundtables.”
The company’s current aim is to focus on formal product definition and gain a fuller understanding of the market. ViBo Health Europe has already received support from the European Space Agency Business Incubation Centre in Portugal and the European Institute of Innovation and Technology. It is now working on several grant applications and hoping to bring in new investors.
